Related Experiment Video
Updated: Feb 10, 2026

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection
Published on: December 19, 2025
Molecular profiling and companion diagnostics: where is personalized medicine in cancer heading?
Abstract:
The goal of personalized medicine is to use the right drug at the right dose - with minimal or no toxicity - for the right patient at the right time. Recent advances in understanding cell biology and pathways, and in using molecular 'omics' technologies to diagnose cancer, offer a strategic bridge to personalized medicine in cancer. Modern personalized medicine takes into account an individual's genetic makeup and disease history before developing a treatment regimen. The future of clinical oncology will be based on the use of predictive and prognostic biomarkers in patient management. Once implemented widely, personalized medicine will benefit patients and the healthcare system greatly.
Insights
Personalized medicine aims to tailor treatments, like cancer therapies, to individual patients using their unique genetic makeup and molecular data. This approach promises more effective care with fewer side effects for better health outcomes.
Area of Science:
- Oncology
- Genomics
- Translational Medicine
Background:
- Personalized medicine aims to optimize drug selection and dosage for individual patients, minimizing toxicity.
- Advances in cell biology, cancer pathways, and molecular 'omics' technologies are crucial for its development.
- Understanding individual genetic makeup and disease history is central to modern personalized treatment strategies.
Purpose of the Study:
- To highlight the strategic role of molecular 'omics' technologies in advancing personalized cancer medicine.
- To emphasize the importance of tailoring treatment regimens to individual patient profiles.
- To underscore the future impact of predictive and prognostic biomarkers in oncology.
Main Methods:
- Leveraging molecular 'omics' technologies for cancer diagnosis.
- Analyzing individual genetic makeup and patient disease history.
- Utilizing predictive and prognostic biomarkers for patient management.
Main Results:
- Personalized medicine offers a strategic bridge to tailored cancer therapies.
- Individualized treatment regimens are developed based on unique patient data.
- Biomarker-driven patient management is key to future clinical oncology.
Conclusions:
- Personalized medicine represents a significant shift in cancer treatment paradigms.
- The integration of 'omics' data and biomarkers will enhance therapeutic efficacy and safety.
- Widespread implementation of personalized medicine is expected to yield substantial benefits for patients and healthcare systems.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Companionate Love
Muscles that Move the Head
The bilateral sternocleidomastoid, or SCM, and the suprahyoid and infrahyoid muscles are significant head flexors. The SCM muscles originate at the sternum and clavicle and attach to the mastoid process of the temporal bone. The SCM contracts bilaterally to bend the head forward, whereas...
Molecular Orbital Theory I
Microorganisms in Medicine and Therapeutics
Molecular Models

